Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study

Noriyuki Kanzaki,1 Yoshiko Ono,1 Hiroshi Shibata,1 Toshio Moritani2 1Institute for Health Care Science, Suntory Wellness Ltd, Seika-cho, Soraku-gun, 2Graduate School of Human and Environmental Studies, Kyoto University, Sakyo-ku, Kyoto, Japan Background: The aim of this study was to investigate th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanzaki N, Ono Y, Shibata H, Moritani T
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/bb7df7544f1048b6baf2986833cb2146
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb7df7544f1048b6baf2986833cb2146
record_format dspace
spelling oai:doaj.org-article:bb7df7544f1048b6baf2986833cb21462021-12-02T05:48:52ZGlucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study1178-1998https://doaj.org/article/bb7df7544f1048b6baf2986833cb21462015-10-01T00:00:00Zhttps://www.dovepress.com/glucosamine-containing-supplement-improves-locomotor-functions-in-subj-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Noriyuki Kanzaki,1 Yoshiko Ono,1 Hiroshi Shibata,1 Toshio Moritani2 1Institute for Health Care Science, Suntory Wellness Ltd, Seika-cho, Soraku-gun, 2Graduate School of Human and Environmental Studies, Kyoto University, Sakyo-ku, Kyoto, Japan Background: The aim of this study was to investigate the ability of a glucosamine-containing supplement to improve locomotor functions in subjects with knee pain.Methods: A randomized, double-blind, placebo-controlled, parallel-group comparative study was conducted for 16 weeks in 100 Japanese subjects (age, 51.8±0.8 years) with knee pain. Subjects were randomly assigned to one of the two supplements containing 1) 1,200 mg of glucosamine hydrochloride, 60 mg of chondroitin sulfate, 45 mg of type II collagen peptides, 90 mg of quercetin glycosides, 10 mg of imidazole peptides, and 5 µg of vitamin D per day (GCQID group, n=50) or 2) a placebo (placebo group, n=50). Japanese Knee Osteoarthritis Measure, visual analog scale score, normal walking speed, and knee-extensor strength were measured to evaluate the effects of the supplement on knee-joint functions and locomotor functions.Results: In subjects eligible for efficacy assessment, there was no significant group × time interaction, and there were improvements in knee-joint functions and locomotor functions in both groups, but there was no significant difference between the groups. In subjects with mild-to-severe knee pain at baseline, knee-extensor strength at week 8 (104.6±5.0% body weight vs 92.3±5.5% body weight, P=0.030) and the change in normal walking speed at week 16 (0.11±0.03 m/s vs 0.05±0.02 m/s, P=0.038) were significantly greater in the GCQID group than in the placebo group. Further subgroup analysis based on Kellgren–Lawrence (K–L) grade showed that normal walking speed at week 16 (1.36±0.05 m/s vs 1.21±0.02 m/s, P<0.05) was significantly greater in the GCQID group than in the placebo group in subjects with K–L grade I. No adverse effect of treatment was identified in the safety assessment.Conclusion: In subjects with knee pain, GCQID supplementation was effective for relieving knee pain and improving locomotor functions. Keywords: normal walking speed, knee-extensor strength, quercetin glycosides, imidazole peptides, vitamin D Kanzaki NOno YShibata HMoritani TDove Medical Pressarticleglucosaminequercetin glycosidesknee painlocomotor functionswalking speedknee-extensor strengthGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1743-1753 (2015)
institution DOAJ
collection DOAJ
language EN
topic glucosamine
quercetin glycosides
knee pain
locomotor functions
walking speed
knee-extensor strength
Geriatrics
RC952-954.6
spellingShingle glucosamine
quercetin glycosides
knee pain
locomotor functions
walking speed
knee-extensor strength
Geriatrics
RC952-954.6
Kanzaki N
Ono Y
Shibata H
Moritani T
Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
description Noriyuki Kanzaki,1 Yoshiko Ono,1 Hiroshi Shibata,1 Toshio Moritani2 1Institute for Health Care Science, Suntory Wellness Ltd, Seika-cho, Soraku-gun, 2Graduate School of Human and Environmental Studies, Kyoto University, Sakyo-ku, Kyoto, Japan Background: The aim of this study was to investigate the ability of a glucosamine-containing supplement to improve locomotor functions in subjects with knee pain.Methods: A randomized, double-blind, placebo-controlled, parallel-group comparative study was conducted for 16 weeks in 100 Japanese subjects (age, 51.8±0.8 years) with knee pain. Subjects were randomly assigned to one of the two supplements containing 1) 1,200 mg of glucosamine hydrochloride, 60 mg of chondroitin sulfate, 45 mg of type II collagen peptides, 90 mg of quercetin glycosides, 10 mg of imidazole peptides, and 5 µg of vitamin D per day (GCQID group, n=50) or 2) a placebo (placebo group, n=50). Japanese Knee Osteoarthritis Measure, visual analog scale score, normal walking speed, and knee-extensor strength were measured to evaluate the effects of the supplement on knee-joint functions and locomotor functions.Results: In subjects eligible for efficacy assessment, there was no significant group × time interaction, and there were improvements in knee-joint functions and locomotor functions in both groups, but there was no significant difference between the groups. In subjects with mild-to-severe knee pain at baseline, knee-extensor strength at week 8 (104.6±5.0% body weight vs 92.3±5.5% body weight, P=0.030) and the change in normal walking speed at week 16 (0.11±0.03 m/s vs 0.05±0.02 m/s, P=0.038) were significantly greater in the GCQID group than in the placebo group. Further subgroup analysis based on Kellgren–Lawrence (K–L) grade showed that normal walking speed at week 16 (1.36±0.05 m/s vs 1.21±0.02 m/s, P<0.05) was significantly greater in the GCQID group than in the placebo group in subjects with K–L grade I. No adverse effect of treatment was identified in the safety assessment.Conclusion: In subjects with knee pain, GCQID supplementation was effective for relieving knee pain and improving locomotor functions. Keywords: normal walking speed, knee-extensor strength, quercetin glycosides, imidazole peptides, vitamin D 
format article
author Kanzaki N
Ono Y
Shibata H
Moritani T
author_facet Kanzaki N
Ono Y
Shibata H
Moritani T
author_sort Kanzaki N
title Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
title_short Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
title_full Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
title_fullStr Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
title_full_unstemmed Glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
title_sort glucosamine-containing supplement improves locomotor functions in subjects with knee pain a randomized, double-blind, placebo-controlled study
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/bb7df7544f1048b6baf2986833cb2146
work_keys_str_mv AT kanzakin glucosaminecontainingsupplementimproveslocomotorfunctionsinsubjectswithkneepainarandomizeddoubleblindplacebocontrolledstudy
AT onoy glucosaminecontainingsupplementimproveslocomotorfunctionsinsubjectswithkneepainarandomizeddoubleblindplacebocontrolledstudy
AT shibatah glucosaminecontainingsupplementimproveslocomotorfunctionsinsubjectswithkneepainarandomizeddoubleblindplacebocontrolledstudy
AT moritanit glucosaminecontainingsupplementimproveslocomotorfunctionsinsubjectswithkneepainarandomizeddoubleblindplacebocontrolledstudy
_version_ 1718400253960388608